Introduction
The discovery that extremely low selenium (Se) intake is a factor in the development of Keshan disease, an endemic cardiomyopathy in parts of China [see (1) ], was a major step towards the demonstration that the micronutrient Se is essential for human health. Subsequently, Se has been suggested to play a role in a wide range of physiological processes, including immune function, thyroid function and male fertility. In addition, higher Se intake has been proposed to lower cancer risk (2) . Se content of food is highly dependent on the concentration of Se in the soil on which the crops were grown or on which the fodder for animals was produced-as a result dietary Se intake varies greatly across the different regions of world and between individuals. Extremely low intake (,10 lg/ day) that results in severe symptoms such as Keshan disease is rare. However, suboptimal Se intake is more commonly observed; for example, in parts of Europe, Se intake is estimated at $30 to 50 lg/day compared with the present Reference Nutrient Intake of 75 and 60 lg/day for men and women, respectively. Thus, although in most populations, Se is not low enough to cause deficiency-associated disease, it may be inadequate for optimal health (3) (4) (5) . Over the past 20 years, such low suboptimal Se intake has been suggested to be associated with increased susceptibility to cancer, including colorectal cancer (CRC). Additionally, mechanistic data suggest a role for selenium and selenoproteins (the biological actors of Se) in colorectal function and cancer prevention in humans and in animal and cell models. In this article, we will assess the evidence for any association between either Se intake or genetic variants in selenoprotein metabolism and CRC risk and summarise the potential mechanistic basis for such possible associations.
Physiological roles of selenium
In the human body, Se is found in 25 selenoproteins as the amino acid selenocysteine (Sec) (6) . Sec is incorporated into the polypeptide chain during selenoprotein translation at specific UGA codons. UGA codons normally signal the termination of translation, and therefore, incorporation of Sec in the peptide chain requires the recoding of these UGA codons from stop to Sec. This recoding is achieved by the presence of (i) a stem-loop structure (Sec-insertion sequence: SECIS) within the 3#-untranslated region (3#-UTR) of the selenoprotein messenger RNA (mRNA), (ii) several proteins that bind to the SECIS structure and (iii) a specific selenocysteyl-tRNA (tRNA-Sec) carrying the Sec amino acid and synthesised from selenide, ATP and seryl-tRNA. All selenoproteins contain one Sec located at the active site of the protein, except selenoprotein P, which contains multiple Sec.
The major selenoproteins are listed in Table I . Most selenoproteins exhibit oxidoreductase activities. For example, five selenoprotein glutathione peroxidases (GPx), three thioredoxin reductases (TR) and three deiodinases (IDI) all function on the basis of Sec contributing to their oxidoreductase activity. GPx1 and GPx2 have antioxidant functions, protecting cells from reactive oxygen species, reactive nitrogen species and oxidative damage. Knockout mice lacking both GPx1 and GPx2 are more susceptible to an oxidative challenge (7) . GPx4 uses lipid hydroperoxides as substrates and has been suggested to have a complex range of functions in protection of cells from oxidative damage, lipoxygenase metabolism and sperm function (6, 8) . TR1-3 have redox functions related to the reduction of ribonucleotides to deoxyribonucleotides, maintenance of redox state and in regulation of transcription factor activity. The iodothyronine deiodinases (IDII, IDIII and IDIIII) are a family of selenoproteins involved in thyroid hormone metabolism (6, 9) . Selenoprotein P (SePP), which accounts for .50% of the total plasma Se content, is a secreted protein that is unique in containing up to 10 Sec residues, the majority of which reside in a Sec-rich C-terminal domain (10) . SePP is present in the blood or plasma as at least two isoforms of $50 and 60 kDa molecular weight (10, 11) . Studies of transgenic mice lacking Sepp gene has shown that the protein has a key function in delivery of Se from liver to extra-hepatic tissues, such as brain and testis (12, 13) . However, in addition to its major expression in the liver, SePP is also expressed in a range of tissues including the colon (10, 14) . Additionally, SePP has been shown to have antioxidant functions in addition to its key transport role. The functions of other selenoproteins are less well characterised but recent work has shown that selenoproteins H, L, T and W (SelH, Sel L, SelT and SelW) and the 15 kDa selenoprotein are members of a novel family of selenoproteins that contain a thioredoxin-like redox fold (6) . SelS, SelN, 15 kDa selenoprotein and SelM are endoplasmic reticulum (ER) proteins that appear involved in redox balance and the unfolded protein response (6, (15) (16) (17) (18) .
Selenoprotein biosynthesis is dependent on dietary Se intake and there is overwhelming evidence that the synthesis of different selenoproteins is affected differentially by low Se intake (6, 19) . This has led to the concept of a hierarchy between selenoproteins in which Se intake affects the synthesis and expression of some selenoproteins more than others and the pattern of response is different in different tissues. Thus, for example, GPx1 protein and mRNA levels are more sensitive to Se deficiency that GPx4 in many tissues, GPx4 more sensitive to deficiency in the liver than the heart and deiodinase activity is less sensitive to Se deficiency in the thyroid than in the liver (19) . Data on the expression of selenoproteins in the colon are very limited but on the basis of mRNA levels (which may in some cases reflect sensitivity of selenoprotein levels to Se supply (20, 21) ) from analysis of a gut epithelial line in culture (22) and a transcriptomic analysis of the mouse colon (23), GPx1, SelW, SelH and SelM appear the most sensitive to Se supply. We have recently highlighted that pathway analysis of the transcriptomic data suggests that Se may affect a number of interacting pathways that affect responses of cells to oxidative, ER and inflammatory stresses (24). On the basis of the known and suggested roles of selenoproteins in cell protection mechanism, it is possible that factors that affect the pattern of colonic selenoprotein expression, such as dietary Se or genetic variation in the selenoprotein genes, may modulate the ability of gut epithelial cells to cope with damaging metabolic challenges.
Epidemiological studies of Se intake and CRC risk
Comparisons of Se intake and cancer mortality rates across the world have suggested that there is an association between lower Se intake and higher overall cancer mortality in different populations (1, 25) . Such data, although weak from an epidemiology standpoint, served as the first stimulus for studies of the relationship between Se intake and CRC risk. The second stimulus was the outcome of the randomised controlled National Prevention of Cancer (NPC) trial carried out in the USA. In this trial, .1000 subjects with a history of non-melanoma skin cancer were given a Se supplement (Seenriched yeast; 200 lg/day) or placebo for 4.5 years and then followed up for a further 6.5 years. Although Se supplementation had no significant effect on melanoma recurrence (the primary endpoint), incidence of CRC was significantly lowered when outcome was assessed after 4.5 years when blinding was removed (26, 27) . Importantly, the supplementation was most effective in subjects within the lowest tertile for plasma Se at the start of the trial (,106 lg/l). Thus, although the effects seen on CRC (and lung and prostate cancers) in this trial were only secondary outcomes, the results suggested that increased Se intake lowered CRC risk in people with a plasma Se ,100 lg/l. It is interesting to note that in this trial, the beneficial effects of Se supplementation on CRC risk were observed despite the relatively high starting Se status-higher than that found in Europe, New Zealand and many parts of the world where mean plasma Se concentrations in the population are ,100 lg/l (5,28). Thus, this effect of Se supplementation might be relevant to many other populations. However, unfortunately, a major intervention trial has not been carried out to directly assess the preventive effect of Se supplementation on CRC risk. The results of the above geographical studies and Se supplementation trial led to a considerable number of relatively small case-control or cohort studies. Broadly speaking, these have assessed the relationship between Se status, assessed by measurement of serum or plasma Se, in controls compared with colon cancer patients, rectal cancer patients, CRC patients or patients with evidence of adenomas but not cancer. The majority of the cancer patient studies were carried out in very small cohorts (many of the order of 25-100 cases). The results from these studies have shown no consistent association between Se status and CRC risk (see Table II ). Several of the studies suggested a possible association between higher Se status and lower CRC risk but in most of these, any observed effect was not statistically significant; in other studies, no effect was observed [see Table II and (40,41) for reviews]. Interestingly, one large cohort study found people who took a Se supplement (dose not known) on a regular basis to have a lower incidence of CRC (36, 42) . On the basis of such mixed results, the World Cancer Research Fund (43) has concluded that there is only limited evidence to suggest foods containing Se protect against CRC (43) . A recent systematic review has also concluded that there is insufficient evidence to link low Se status to increased CRC risk (44) .
In contrast, although there have been relatively few studies that have investigated the relationship between adenoma occurrence or recurrence as a function of Se status, the outcome of such studies has been more consistent in suggesting that higher Se status is associated with lower risk of development of these precancerous lesions that increase the likelihood of CRC (see Table II ). An early US study (28 cases and 20 controls) showed that colonoscopy patients with a lower plasma Se were more likely to be found to have one or more adenomatous polyps (35) . Subsequently, a second small study (37 cases and 36 controls) in USA showed patients with CRC to have a lower mean plasma Se than controls and the difference almost reached statistical significance (36) . A third small study, based in Spain, showed a significant inverse association between Se status and occurrence of large adenomatous polyps (45) . However, two other small US studies have failed to confirm such findings (34, 38) .
More recently, Jacobs et al. combined data from three randomised trials in USA (the Wheat Bran Fiber Trial, the Polyp Prevention Trial and the Polyp Prevention Study) to analyse adenoma recurrence in relation to blood selenium (39) . Although individually the three trials failed to show any significant association between blood selenium and risk of adenoma, when the data from the three trials were pooled (1012 cases and 751controls), there was a statistically significant difference in the odds of developing a new adenoma between individuals with high and low blood Se concentrations, with lower Se in the group who developed adenomas. The relationship between adenoma occurrence and serum Se concentration was also investigated in patients (758 cases and 767 controls) randomly selected from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (37) . The results showed a statistically significant inverse association between serum Se and advanced colorectal adenoma in recent smokers but there was no association in non-smokers or former smokers who had stopped quit smoking !10 years previously. Genetic polymorphisms in selenoprotein genes and CRC risk
As described in Physiological roles of selenium, selenoprotein synthesis is unique in requiring a specific 3#-UTR-based mechanism for Sec incorporation. Therefore, potentially, it can be expected that single-nucleotide polymorphisms (SNP) within selenoprotein gene regions corresponding to the 3#-UTR can affect selenoprotein synthesis. Indeed, several such SNP have now been found to be functional and together with SNP in promoter and coding regions they can influence selenium metabolism (46) . A proline to leucine variant at codon 198 in the GPX1 gene (rs1050450) causes functional changes (47) . This SNP is found widely in different ethnic groups but the leucine variant, which exhibits a lower enzymatic activity, is relatively rare (7-15%). The SNP has been shown to influence the relationship in vivo between GPX1 activity and Se concentration (48) . In addition, several SNPs in the plasma glutathione peroxidase gene (GPX3) have been reported to affect its promoter activity (49) . Similarly, a SNP in the 3#-UTR region of the GPX4 gene (rs713041) has been found in several ethnic groups (50) (51) (52) . A wide range of experimental data have shown that this SNP has functional effects in vitro and in vivo. In vitro, the C variant shows stronger binding to Caco-2 cell proteins than the T variant (53) and greater capacity to direct the expression of a selenoprotein reporter gene in transfected cells (54) . Recent studies with selected clones of Caco-2 cells over-expressing comparable levels of the reporter gene linked to either the GPX4 T or the C variant 3#-UTR indicate that the SNP interferes with expression of other selenoprotein including GPx1 and SelH, presumably by affecting the hierarchy of selenoprotein synthesis to different extents (55) . In vivo studies have shown that this SNP was able to affect lymphocyte GPx1 protein levels and the ratio of GPx1:GPx4 protein concentrations (53) . Taken together, these data suggest that the C variant 3#-UTR from GPX4 competes more strongly than the T variant for one or more proteins involved in Se incorporation and as a result the SNP affects the hierarchy of selenoprotein synthesis (53) . Computer prediction suggests that the SNP alters the structure of the 3#-UTR in the vicinity of the SECIS and our hypothesis is that this affects the binding of proteins involved in selenocysteine incorporation and thus selenoprotein synthesis (54) .
The promoter, coding sequence and 3#-UTR of the SEPP1 gene have been found to contain variants with functional consequences. A variant in a TC repeat sequence within the promoter affects reporter activity in HepG2 cells (14) . A G/A SNP within the 3#-UTR (rs7579) and a G/A SNP that causes an alanine to threonine amino acid change at codon 234 (rs3877899) were both shown to be functional as they affect the response to supplementation of human lymphocyte GPx4 and GPx1, plasma GPx3 and TR1 and erythrocyte TR1 (56) . In addition, both variants affected the proportion of 50 and 60 kDa isoforms of SePP in plasma and their relationship with lymphocyte GPx4 levels (11) . Overall, the results of these studies suggest various variants in SEPP1 can affect delivery of Se for synthesis of other selenoproteins.
The 15 kDa selenoprotein and selenoprotein S have recently been found to have roles in the ER stress response (15, 16) . The genes encoding these proteins have both been reported to have SNPs that affect expression of the selenoprotein. In SEP15, there are two linked variants in the gene region that encodes the 3#-UTR, a C/T substitution at position 811 (rs5845) and a G/A at position 1125 (rs5859) and these SNPs are thought to be functional based on reporter gene experiments (57) . A SNP in the SELS promoter at position À105 (rs34713741) has been found to affect levels of inflammatory markers such as TNFalpha and interleukin and is regarded as having functionally significant effects (58) .
The functionality of the SNPs described above reflects the region of the gene in which they are located (Table III) . SNPs located in regulatory regions, such as the promoter region (this is the case for SELS, GPX3 and SEPP1 genes) or the 3# untranslated regions (SEPP1, GPX4 and SEP15), have the capacity to alter the level of expression of the selenoprotein, whereas coding SNPs altering the protein sequence have the capacity to affect the stability or activity of the corresponding protein (SEPP1 and GPX1).
None of these SNPs or other SNPs in selenoprotein or related genes has been associated with CRC risk by genomewide association studies (GWAS). However, a number of small-scale genotyping studies have been carried out and there are indications of links between at least one SNP and CRC risk.
In a study of a relatively small Scottish population ($300 cases and 189 controls), carriage of the C variant of rs713041 in the GPX4 gene was found to be associated with CRC but not with increased risk of having adenomatous polyps (54) . Recently, however, this association was not replicated in a Korean population (52) and, in contrast, in a Czech population (832 cases and 705 controls), the T variant was found associated with increased CRC risk (51) . Measures of Se status were not available in the analyses of Czech and Korean subjects so it is not possible to assess the influence of Se status on the impact of this SNP on disease risk. However, in this regard, it is interesting that in the UK study (54) , preliminary data suggested that in CRC patients Se status, as assessed by plasma Se levels and erythrocyte GPx1 activity, were significantly lower in individuals with CC genotype than in individuals with CT or TT genotype.
In addition, genotyping for known functional SNPs in selenoprotein genes in the Czech (832cases and 705 controls) and Korean (827 cases and 727 controls) studies has shown that other genetic variants may influence CRC risk (51, 52) . Importantly, in both populations, SNPs in the promoter region of SELS were found to modulate disease risk with the T allele of rs34713741 increasing CRC risk and showing an odds ratio of 1.68 (1.16-2.43) in the Czech population and carriage of a second variant in close proximity leading to an odds ratio of 2.25 for homozygous females in the Korean population. The replication of the association in these two distinct populations strongly suggests that regardless of other genetic, lifestyle and dietary factors SNPs in SELS promoter influence CRC risk. Interestingly, rs34713741 has been shown to influence markers of inflammatory function (58) and the SNP has been linked to gastric cancer risk (61) . Not only do these studies suggest that SNPs in SELS may influence CRC risk but they also identify SelS as a potentially important factor in our understanding of the mechanisms by which Se may protect gut epithelial cells from tumourigenesis.
Additionally, in the Czech population, significant genetic interactions were observed between rs4880 (SOD2), rs713041 (GPX4) and rs960531 (TXNRD2) and between SEPP1 and either SEP15 or GPX4 (51) suggesting that function of multiple selenoproteins in the colon affects CRC risk. Biologically, these interactions reflect the combined metabolic interactions of GPx4, TR2 and MnSOD in the response to oxidative stress and SePP in the delivery of Se for synthesis of selenoproteins. The potential importance of variants in SEPP1 is highlighted by results from a genotyping study of subjects from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (59) in whom 44 tagged SNPs in GPX1, GPX2, GPX3 and GPX4, SEPP1 and thioredoxin reductase 1 (TXNRD1) genes were studied and four variants in SEPP1 and one in the TXNRD1 were found to be significantly associated with risk of adenoma: one C/G variant in the 5#-gene region of SEPP1 at À4166, three in 3#-gene region of SEPP1 and one in TXNRD1 at position À181. In addition, there was a significant overall association with adenoma risk for all the variants of SEPP1 and TXNRD1.
Selenoprotein synthesis is highly dependent on dietary Se intake and so it is to be expected that the influence of the SNP described here could be modified by Se intake. For that reason, it will be vital in future work to combine genotyping for selenoprotein SNPs with measures of Se status. The importance of such gene-diet interactions, as well as potential involvement of other lifestyle factors such as smoking, may be the reason why selenoprotein SNPs have not been identified as CRC risk factors in GWAS.
Effect of Se on colonic function in human and animal studies
In both humans and mice, dietary supplementation with selenium has been found to influence selenoprotein expression. Supplementation of mice with 1 ppm Se-enriched milk protein increased the expression of GPx2 and SePP in the mouse colon (62) and in humans, 6-week-supplementation with Se-enriched milk protein (150 lg/day) resulted in an increased expression of GPx1, GPx2 and SePP mRNAs in rectal biopsies (63) . Additionally, Se supplementation prevents tumour development in mouse models of colon carcinogenesis. For example, supplementation with 1 ppm Se-enriched milk protein was protective against azoxymethane-induced aberrant crypt and tumour formation in a mouse model of CRC (64) . Further evidence linking selenium, selenoproteins and colon carcinogenesis has come from the development of transgenic mice with genetically impaired selenoprotein expression as they carry a mutant selenocysteine transfer RNA (TRSP gene) gene (65) . Such mice exhibit reduced colon glutathione peroxidase expression compared with wild-type mice (but an unchanged thioredoxin reductase expression) regardless of Se intake and a larger number of azoxymethane-induced aberrant crypts. In addition, in both mutant and wild-type mice, Se supplementation lowered the number of aberrant crypts. Together, these findings indicate that dietary Se supplementation lowers the development of pre-neoplastic lesions in the mouse azoxymethane-induced CRC model, but the precise link between Se intake, specific selenoprotein(s) and these effects is not clear and it has been suggested that the effect of Se may be partly through effects of low molecular weight selenocompounds. In addition, studies on nude mice with xenografts containing human colorectal carcinoma SW480 cells show reduced tumour growth after injection of either sodium selenite or selenomethionine for 3 weeks (66), so supporting the hypothesis that Se supplementation can reduce tumour growth in a colonic environment.
The literature discussed in the preceding sections indicates that there is good evidence that Se intake influences adenoma occurrence in humans and development of aberrant crypts in mouse models of CRC. Thus, although the epidemiological evidence to link CRC risk and Se intake is not particularly strong, these data point to a role of Se and selenoproteins in epithelial cell function such that they influence the development of pre-neoplastic lesions.
Selenoprotein expression and function in colonic cells
As described in Physiological roles of selenium, the biological functions of Se are mainly carried out through its presence in selenoproteins. Selenoprotein biosynthesis depends on Se availability and selenoproteins are involved in many pathways that can influence carcinogenesis (e.g. redox regulation and oxidative stress response, protein folding), and therefore, they represent strong candidates to provide a mechanistic basis of the preventive role of Se. Indeed, studies of both colonic tissue and gut epithelial cell lines provide clues as the selenoproteins and metabolic events that could underlie the effects of Se intakes and SNPs in selenoprotein genes on colonic cell function.
There is a range of data suggesting that Se and selenoproteins modulate inflammatory processes in the colon and both glutathione peroxidases and selenoprotein S have been suggested to play roles in the regulation of inflammatory processes. Due to their antioxidant properties, many selenoproteins, including GPx1, 2, 4 and TR1 and 2, play roles in protecting cells from damaging free radical species, in redox Functional SNPs are listed together with their localisation in the gene/transcript and any reported association with risk of CRC or adenoma.
Selenium, SNP and CRC risk control and in limiting gut inflammation, which has been proposed to be an important event in development of CRC (67) . GPx1 is a ubiquitous cytosolic enzyme that catalyses the metabolism of peroxides, and GPx2 has similar activity but is has a restricted tissue distribution with high expression in gut cells. GPx4, which exists as cytosolic and mitochondrial isoforms, uses lipid hydroproxides as substrates and has been implicated in protecting cells from lipid peroxides (6, 8) ; it has been suggested to also modulate arachidonic acid and leukotriene metabolism (potent pro-inflammatory mediators) and apoptotic pathways (68) . Transgenic knockout mice lacking GPX1 and GPX2 have increased gut inflammation after a bacterial challenge (69) and GPx4 has been suggested to affect leukotriene metabolism (50, 68) . TR1 and 2, as mentioned above, are also involved in redox control and have been proposed to protect cells from oxidative damage, including DNA damage, a function that could protect gut cells from developing changes in growth characteristics. Moreover, they have been suggested to play a role in redox regulation of transcription factors such as NFjB (70) . In addition, there is evidence that the SEPP1 promoter contains cytokine-response elements (71) and that SePP expression in the Caco-2 epithelial cell line responds to cytokines such as TNF-alpha and IFN-gamma (72) . Furthermore, SePP mRNA levels have been observed to increase in the mouse colon during experimentally induced colitis (72) . SelS is an ER chaperone that contributes to the removal of misfolded protein from the ER to the cytosol (6) and thus influences inflammatory signalling pathways. The association of a SNP in SELS with CRC risk (51, 52) suggests that changes in ER folding and inflammatory pathways associated with altered SelS expression can have important effects on colonic cell growth.
Recently, a transcriptomic analysis has provided potential new insights into the biochemical response of the colon to low Fig. 1 . Schematic diagram illustrating the potential consequences of changes in Se intake on signalling pathways in the colon. Taken together the known roles of selenoproteins and data from the literature describing effects of Se intake or selenoprotein gene variants suggest that Se intake is likely to affect the pathways illustrated-Wnt signalling, mTOR signalling, Nrf2 and NF-jB signalling and ER and oxidative stress responses. Note that many of the affected pathways modulate the response of cells to metabolic or extracellular challenges and how cells respond in terms of cell growth and proliferation. In addition, there is potential biochemical crosstalk between the pathways. Delta, variations in dietary Se intake; Fzd, Frizzled; LRP, lipoprotein receptor; Dsh, dishevelled; b-cat, b-catenin; APC, adenomatous polyposis coli; CK1a, casein kinase 1a; Gsk3b, glycogen synthase kinase 3-beta; S6K, ribosomal protein S6 kinase; 4EBP, eukaryotic translation initiation factor 4E-binding protein; IKK, IjB kinase; Keap1, Kelch-like ECH-associated protein 1; GPx, glutathione peroxidases; SOD, superoxide dismutases; TR, thioredoxin reductase; ROS, reactive oxygen species. Proteosomal degradation is indicated by the following icon:
Se intake and the mechanism of action of Se on colonic function (23, 73) . Although interpretation of mRNA levels in terms of selenoprotein expression has its limitations, the gene microarray analysis of RNA isolated from the colon of mice fed either a Se-adequate or a marginally Se-deficient diet for 6 weeks showed low Se intake led to lower expression of GPx1, SelH, SelW and SelM (23) . The sensitivity of GPx1 expression in many tissues to low Se is well known (19) and SelW expression was found to be sensitive to Se supply in Caco-2 cells (22) . However, the data from the mouse experiment suggest that in the colon, expression of SelH and SelM is also sensitive to Se intake. To better understand the impact of low Se intake on colonic function, it will be necessary to further study the regulation and clarify the roles of SelH, SelW and SelM, about which little is known to date (6) .
In addition to the role played by Se and selenoproteins in the response to oxidative and ER stress, transcriptomic data revealed that changes in dietary Se intake affects several pathways in the mouse colon (23): Wnt signalling pathway, protein synthesis and the regulation of eiF4E and p70S6 kinase, ribosomal proteins, mammalian target of rapamycin (mTOR) signalling pathway, NFjB pathway and proteasome degradation and Nrf2-regulated pathways (23, 73) . Figure 1 presents an overview of the pathways and stress responses which are modulated by changes in dietary Se and/or in which selenoproteins are proposed to function. Potentially, coordination of these signalling pathways plays an important role in the response of colonic cells exposed to external challenges such as cytokines, growth factors, bacteria and food-derived prooxidant molecules and xenobiotics. Critically, de-regulation of these signalling pathways has been associated with the carcinogenic process.
The Wnt signalling pathway, which regulates cell proliferation via the stabilisation of b-catenin, under binding of Wnt ligands to the Frizzled receptor and lipoprotein receptor (LRP5/6), was shown to be affected by changes in dietary Se (23) . Mutations in genes from the Wnt pathways, such as adenomatous polyposis coli, are commonly observed in adenoma and at early stage of carcinogenesis and result in a hyperactivation of Wnt signalling.
Signalling pathways modulating translational control have been identified as key mechanisms in oncogenesis (74, 75) . The mTOR signalling integrates signalling pathways controlling cell growth and modulates several key components involved in mRNA translation, in particular (via repressor proteins) the capbinding initiation factor eIF4E, the ribosomal protein p70S6 kinases and elongation factors (76) . Additionally, crosstalk between c-myc transcriptional regulation (a target gene of the Wnt pathway) and mTOR nutrient sensing pathway has been shown using microarray approach through their intersecting effects on translation initiation and elongation (77) . Thus, it is possible to envisage that the effect of Se on translation reflects its capacity to modulate Wnt and/or mTOR signalling.
Similarly, Se supply has been shown to affect NFjB and Nrf2 signalling (23, 73, 78, 79) . Upon stimulation, both transcription factors release cytoplasmic anchoring inhibitory molecules (IjB and Keap1, respectively), which are targeted for proteasomal degradation. As a result, the transcription factors translocate to the nucleus and activate the expression of target genes. NFjB regulates the expression of genes involved in the inflammatory response, apoptosis and cell survival, whereas Nrf2 regulates the expression of phase II enzymes. During inflammation and carcinogenesis, NFjB and Nrf2 signalling pathways are regulated in concerted manner via the modulation of crosstalk (80, 81) .
Various stresses, such as hypoxia, nutrient starvation and oxidative stress reduce the protein folding capacity of the ER, leading to a condition referred to as ER stress and resulting in the accumulation and aggregation of misfolded proteins (82) . Severe or prolonged ER stress can ultimately lead to apoptotic cell death (83,84). As described above, several selenoproteins have been identified in the ER (SeP15, SelH, SelM, SelN and SelS) where they contribute to the removal of misfolded proteins from the ER lumen and to inflammatory signalling, therefore reducing ER stress (15) (16) (17) 58) . On the other hand, the sensitivity of these selenoproteins to Se supply, and the presence of functional SNPs in their genes, suggest that either the reduction of Se supply or the genetic factors could exacerbate ER stress (58) .
There is evidence for biochemical interactions between ER stress, oxidative stress, Nrf2 pathways and inflammation but it is not clear how, or if, these interactions are altered by Se intake. Interestingly, a recent analysis of colonic biopsy material has suggested that NFjB activation is altered in the adenoma to adenocarcinoma transition (85) . On the basis of the above pathway analysis together with both the known functions of selenoproteins such as glutathione peroxidases and SelS in responses to oxidative and ER stress and the sensitivity of other colonic selenoproteins such as SelH to Se intake, we hypothesise that Se, through the selenoproteins, plays a key role in the ability of colonic epithelial cells to cope with such challenges and that a combination of low Se intake and SNP in selenoprotein genes can impair that role. Understanding the role of Se and selenoproteins in the regulation of these pathways and the coordination of responses to oxidative and ER stresses could provide new insight on how Se could prevent the development of CRC.
Conclusions and future perspectives
As discussed in the previous sections, data from studies in cell culture, animal models and humans all show that selenoprotein expression in colonic cells is altered by Se intake. Furthermore, there is a selenoprotein hierarchy with expression of some selenoproteins being more sensitive to variations of Se intake than others. Several studies indicate that, as assessed by mRNA levels, expression of GPx1, SelW, SelH, SeP15 and SelM are particularly sensitive to Se intake (22, 23) . It is not known if the pattern of selenoprotein expression is the same throughout the colon and rectum. Interestingly, a DNA-repeat in the SEPP1 promoter has been reported to be genetically unstable under conditions of mismatch repair deficiency (14) , suggesting a potential link between DNA repair and selenoprotein metabolism. As DNA mismatch repair-deficient tumours are frequently located in the ascending colon in both sporadic and hereditary [such as non-polyposis colon cancer (HNPCC)] CRC (86), it will be important to clarify the roles and expression of selenoproteins in the different regions of the colon and rectum.
In addition, genetic association studies suggest that a SNP in SELS influences risk of CRC. It also appears that genetic interactions between other variants may influence CRC risk. Elucidating the effects of genetic variants on risk of both rectal and colonic disease and the identification of genetic interactions between functional SNPs provides a focus for future genetic epidemiology studies and not only could these variants represent potential biomarkers of disease risk but they could also help identify key biological interactions within selenoprotein metabolism in the epithelium of the large bowel.
At present, the functions of SelW, M and H are poorly understood, while SelS and 15 kDa selenoprotein are thought to be involved in the ER protein misfolding response and the GPx1 in oxidative defence. Furthermore, a SNP in the SELS gene has been found to influence the production of inflammatory markers (58) , suggesting that its role in the ER stress response (6) results in changes in inflammatory signalling pathways. In addition, studies of transgenic mice lacking GPX1 and GPX2 indicate that these selenoproteins influence microbial-induced inflammation (69) . Future research needs to clarify the functions of this range of selenoproteins in colorectal epithelial cells, particularly in relation to the pathways identified by transcriptomics as being Se sensitive-inflammatory signalling pathways, ER and oxidative stress pathways and Nrf2 regulation. Since gut inflammation has been proposed to be an important event in development of CRC (67) . It will be important in future work to explore the relationship between these selenoproteins and inflammatory events and the responses of the colonic epithelial cells to different metabolic challenges (see Figure 1 ).
To date, epidemiological studies have provided only weak evidence to link CRC risk and Se intake. However, there are several sets of data that suggest that despite such epidemiological studies, Se intake may affect adenoma and CRC risk. Firstly, the one major intervention trial (26) suggests increased Se intake may lower CRC risk. Secondly, there is increasing evidence that Se intake influences both adenoma occurrence and reoccurrence in humans [see Table II (37, 39, 40) ]. Thirdly, Se intake modulates development of aberrant crypts in a mouse model of CRC (64) . Fourthly, two studies indicate an association between a SNP in SELS and CRC risk (51, 52) . Thus, present data point to a role of Se and selenoproteins in epithelial cell function such that they influence the development of preneoplastic lesions but although the evidence to link adenoma and CRC risk and Se intake and function is not as yet sufficient to be a basis for recommendation of Se supplementation, for CRC prevention, it is strong enough to emphasise the need for further research in this area. In particular, there is a need for both an epidemiological study to assess the combined influence of Se intake and selenoprotein SNPs on adenoma and CRC risk and a major intervention study with Se supplementation in a population with a habitual Se intake that is low or suboptimal (e.g. Europe) rather than the USA, where Se intake is already higher. Using such a study, population should improve the chance to observe any beneficial effect of Se and avoid adverse effects. These studies should have as large numbers as possible so as to achieve the necessary statistical power, and be as complete as feasible by including both genotyping for various SNPs, and measures of biomarkers of Se status. To support such studies, further understanding of functions of key selenoproteins in epithelial cells of the colon and rectum, and how these functions alter in response to Se intake, is required. 
